List of Progress in Hematology "Review Series" 2014-2015
***2015***
Molecular pathogenesis and treatment strategies ofadult leukemia (Edited by Kazunori Ohnishi)
1.
Patel B, Hirsch C, Clemente M, Sekeres M, Makishima H, Maciejewski JP. Genetic and molecular characterization of
myelodysplastic syndromes and related myeloid neoplasms. Int. J. Hematol. 101: 213-8, 2015
2.
Rodríguez D, Bretones G, Arango JR, Valdespino V, Campo E, Quesada V, López-Otín C. Molecular pathogenesis of CLL and its
evolution. Int. J. Hematol. 101: 219-28, 2015
3.
Zoi K, Cross NCP. Molecular pathogenesis of atypical CML, CMML and MDS/MPN-unclassifiable. Int. J. Hematol. 101:229-42, 2015
4.
Yanada M. Allogeneic hematopoietic cell transplantation for acute myeloid leukemia during first complete remission: a clinical
perspective. Int. J. Hematol. 101:243-54, 2015
Transcriptional control in myeloid cell development and related diseases (Edited by Tomohiko Tamura)
1.
Imperato MR. Cauchy P, Obier N, Bonifer C. The RUNX1–PU.1 axis in the control of hematopoiesis. Int. J. Hematol. 101: 319-29,
2015
2.
Friedman AD. C/EBPa in normal and malignant myelopoiesis. Int. J. Hematol. 101: 330-41, 2015
3.
Tamura T, Kurotaki D, Koizumi S. Regulation of myelopoiesis by the transcription factor IRF8. Int. J. Hematol. 101:342-51, 2015
4.
Yokoyama A. Molecular mechanisms of MLL-associated leukemia. Int. J. Hematol. 101:352-61, 2015
The latest development in GVHD management (Edited by Makoto Murata)
1.
Shono, Y, Docampo MD, Peled JU, Perobelli SM, Jenq RR. Intestinal microbiota-related effects on graft-versus-host disease. Int. J.
Hematol. 101: 428-37, 2015
2.
Nakasone H, Sahaf B, Miklos DB. Therapeutic benefits targeting B-cells in chronic graft-versus-host disease. Int. J. Hematol.
101:438-51, 2015
3.
Jamil MO, Mineishi S. State-of-the-art acute and chronic GVHD treatment. Int. J. Hematol. 101:452-66, 2015
4.
Murata M. Prophylactic and therapeutic treatment of graft-versus-host disease
in Japan. Int. J. Hematol. 101:467-86, 2015
Preleukemia/prelymphoma (Edited by Shigeru Chiba)
1.
Shlush LI, Zandi S, Itzkovitz S, Schuh AC. Aging, clonal hematopoiesis and preleukemia: not just bad luck? Int. J. Hematol.
102:513-22, 2015
2.
Sakata-Yanagimoto M. Multistep tumorigenesis in peripheral T cell lymphoma. Int. J. Hematol. 102:523-27, 2015
3.
Kikushige Y, Miyamoto T. Pre-malignant lymphoid cells arise from hematopoietic stem/progenitor cells in chronic lymphocytic
leukemia. Int. J. Hematol. 102:528-35, 2015
***2014***
Immunotherapy for hematological malignancies (Edited by Norimitsu Kadowaki)
1. Bocchia M, Defina M, Aprile L, Sicuranza A. Peptide vaccines for hematological malignancies: a missed promise? Int. J. Hematol.
99:107-116, 2014
2. Kitawaki K. DC-based immunotherapy for hematological malignancies. Int. J. Hematol. 99:117-122, 2014
3. Fujiwara H. Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific
receptors. Int. J. Hematol. 99:123-131, 2014
4. Turtle CJ. Chimeric antigen receptor modified T cell therapy for B cell malignancies. Int. J. Hematol. 99:132-140, 2014
Peripheral T cell lymphoma (Edited by Masaki Yasukawa)
1. Piccaluga PP, Tabanelli V, Pileri SA. Molecular genetics of peripheral T-cell lymphomas. Int. J. Hematol. 99:219-226, 2014
2. Park S, Ko YH. Peripheral T cell lymphoma in Asia. Int. J. Hematol. 99:227-239, 2014
3. Ohshima K, Niino D, Karube K. Microenvironment of adult T-cell leukemia/lymphoma-associated nodal lesions. Int. J. Hematol.
99:240-248, 2014
4. Intlekofer AM, Younes A. From empiric to mechanism-based therapy for peripheral T cell lymphoma. Int. J. Hematol. 99:249-262,
2014
Recent Progress in Gene Therapy (Edited by Keiya Ozawa)
1. Davila ML, Bouhassira DCG, Park JH, Curran KJ, Smith EL, Pegram HJ, Brentjens R. Chimeric antigen receptors for the adoptive
T cell therapy of hematologic malignancies. Int. J. Hematol. 99:361-371, 2014
2. Patel N, Reiss U, Davidoff AM, Nathwani AC. Progress towards gene therapy for haemophilia B. Int. J. Hematol. 99:372-376, 2014
3. Uchibori R, Tsukahara T, Ohmine K, Ozawa K. Cancer gene therapy using mesenchymal stem cells. Int. J. Hematol. 99:377-382,
2014
4. Candotti F. Gene transfer into hematopoietic stem cells as treatment for primary immunodeficiency diseases. Int. J. Hematol.
99:383-392, 2014
Noncoding RNA in hematopoietic system (Edited by Ai Kotani)
1. Alvarez-Dominguez JR, Hu W, Gromatzky AA, Lodish HF. Long noncoding RNAs during normal and malignant hematopoiesis. Int.
J. Hematol. 99:531-541, 2014
2. Ikeda S, Tagawa H. Dysregulation of microRNAs and their association in the pathogenesis of T-cell lymphoma/leukemias. Int. J.
Hematol. 99:542-552, 2014
3. Okuyama K, Ogata J, Yamakawa N, Chanda B, Kotani A. Small RNA as a regulator of hematopoietic development, immune
response in infection and tumorigenesis. Int. J. Hematol. 99:553-560, 2014
Hematopoietic regulators in the marrow: new players in inter-organ communication (Edited by Yoshio Katayama)
1. Asada N, Katayama Y. Regulation of hematopoiesis in endosteal microenvironments. Int. J. Hematol. 99:679-684, 2014
2. Casanova-Acebes M, A-González N, Weiss LA, Hidalgo A. Innate immune cells as homeostatic regulators of the hematopoietic niche.
Int. J. Hematol. 99:685-694, 2014
3. Yamazaki S, Nakauchi H. Bone marrow Schwann cells induce hematopoietic stem cell hibernation. Int. J. Hematol. 99:695-698, 2014
4. Kunisaki Y, Frenette PS. Influences of vascular niches on hematopoietic stem cell fate. Int. J. Hematol. 99:699-705, 2014
Basic and Clinical Updates in Acute Promyelocytic Leukemia (Edited by Norio Komatsu)
1. Nakahara F, Weiss CN, Ito K. The role of PML in hematopoietic and leukemic stem cell maintenance. Int. J. Hematol. 100:18-26,
2014
2. Ikezoe T. Pathogenesis of disseminated intravascular coagulation in patients with acute promyelocytic leukemia, and its treatment
using recombinant human soluble thrombomodulin. Int. J. Hematol. 100:27-37, 2014
3. Li J, Zhu H, Hu J, Mi J, Chen S, Chen Z, Wang Z. Progress in the treatment of acute promyelocytic leukemia: optimization and
obstruction. Int. J. Hematol. 100:38-50, 2014
Epigenetic regulation of lymphopoiesis (Edited by Takafumi Yokota)
1. Yoshida T, Georgopoulos K. Ikaros fingers on lymphocyte differentiation. Int. J. Hematol. 100:220-229, 2014
2. Shimazaki N, Lieber MR. Histone methylation and V(D)J recombination. Int. J. Hematol. 100: 230-237, 2014
3. Yokota T, Kanakura Y. Role of tissue-specific AT-rich DNA sequence-binding proteins in lymphocyte differentiation. Int. J. Hematol.
100:238-245, 2014
4. Johanson TM, Skinner JPJ, Kumar A, ZhanY, Lew AM, Chong MMW. The role of microRNAs in lymphopoiesis. Int. J. Hematol.
100:246-253, 2014
Hematopoietic Stem Cell Aging and Chronic Lymphocytic Leukemia Pathogenesis (Edited by Toshio Suda)
1. Nakamura-Ishizu A, Suda T. Aging of the hematopoietic stem cells niche. Int. J. Hematol. 100:317-325, 2014
2. Oshima M, Iwama A. Epigenetics of hematopoietic stem cell aging and disease Int. J. Hematol. 100:326-334, 2014
3. Kikushige Y, Miyamoto T. Hematopoietic stem cell aging and chronic lymphocytic leukemia pathogenesis Int. J. Hematol.
100:335-340, 2014
New and old wonders of erythropoiesis (Edited by Kenichi Sawada)
1. Takashi Moriguchi T, Yamamoto M. A regulatory network governing Gata1 and Gata2 gene transcription orchestrates erythroid
lineage differentiation. Int. J. Hematol. 100:417-424, 2014